Read the most current update to the NCCN Guideline on the treatment of colon and rectal cancers, posted on Medscape, for your convenience. Medscape Hematology-Oncology
Read the most current update to the NCCN Guideline on the treatment of non-small cell lung cancer, posted on Medscape, for your convenience. Medscape Hematology-Oncology
The FDA has approved revisions to the safety labeling for alemtuzumab intravenous injection (Campath) and oxcarbazepine tablets/oral suspension (Trileptal). Medscape Medical News
Dramatic results showing that radioimmunotherapy with Zevalin prolongs progression-free survival by 2 years come just days after cuts in reimbursement for this therapy were announced in the United States. Medscape Medical News
For the first time, a significant prolongation of survival has been seen in this disorder, leading to calls for azacitidine to be offered to all high-risk patients. Medscape Medical News
Using low-dose dexamethasone with lenalinomide instead of high-dose dexamethasone in newly diagnosed multiple myeloma patients confers a significant survival advantage and has less toxicity. Medscape Medical News
At 2-year follow-up, dasatinib continued to demonstrate efficacy and prolong survival among patients with chronic myelogenous leukemia who are either intolerant or resistant to treatment with imatinib. Medscape Medical News
Although lymphedema associated with breast cancer treatment is not currently curable, early detection, treatment, and maintenance contribute to better outcomes. Medscape Hematology-Oncology
In this Expert Interview, Dr. Charles D. Blanke discusses key clinical trials in colorectal cancer and identifies important factors that influence patient assessment and referral. Medscape Hematology-Oncology
